Vaccines for epidemic infections and the role of CEPI
The author reviews the foundation of the Coalition for Epidemic Preparedness and Innovations and the choices it has made for funding of vaccine development against epidemic diseases. He comments on those decisions as well as proposing how CEPI could remain relevant for the long term.
Main Author: | Stanley A. Plotkin |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-12-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2017.1306615 |
Similar Items
-
Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
by: Katie Ewer, et al.
Published: (2017-12-01) -
Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
by: Anahita Fathi, et al.
Published: (2019-10-01) -
Identifying Suspect Bat Reservoirs of Emerging Infections
by: Daniel Crowley, et al.
Published: (2020-05-01) -
La Fièvre Hémorragique à Virus Lassa au Bénin en 2014 en contexte d’Ebola : une épidémie révélatrice de la faiblesse du système sanitaire
by: Emmanuel N’koué Sambiéni, et al. -
Analysis of Determinants in Filovirus Glycoproteins Required for Tetherin Antagonism
by: Kerstin Gnirß, et al.
Published: (2014-04-01)